Skip to content
TDIA

Specialty guide

An aesthetic result is not the end of the surgical responsibility.

Plastic surgery risk runs from candidacy and informed consent through recovery, after-hours care, revision decisions, and the coverage terms that apply to the real practice.

A clinical worktable holds instruments used across medical specialties

The incision is closed, the patient is discharged, and the work is not over. A plastic-surgery practice needs a clear answer when swelling changes, a drain stops working, a patient sends a photo after hours, or a pathology result requires another decision. The patient needs to know who owns the next action before a complication tests the system.

This guide starts with that clinical system. Coverage is a final comparison against the actual people, services, locations, and entities. It cannot create clinical authority or repair a weak handoff.

Build one complete surgical episode

Map each service from first inquiry through the final planned follow-up: indication or candidacy; assessment; alternatives and consent; procedure; anesthesia; recovery; discharge; after-hours contact; pathology, implants, or device follow-up; and revision, referral, or escalation if the expected course changes.

Use the actual procedure, not the word "plastic surgery." A hospital reconstruction, office scar revision, breast procedure, hand procedure, body contouring operation, gender-affirming procedure, laser treatment, and filler injection can have different teams, sites, physiologic demands, and follow-up paths.

For every handoff, name the clinician and backup who receives the information and makes the next decision. A signed consent form, a before-and-after photo, or a discharge packet does not show that the patient has a reachable clinical owner.

Make candidacy and communication part of the procedure

An elective procedure does not remove the need for a defensible clinical decision. Define the patient problem, relevant history, realistic benefit and limitation, alternatives, contraindications, recovery demands, and the point at which the team recommends delay, referral, or no treatment.

The medical record should let the next clinician understand the plan: assessment, procedure and anatomy, implant or device where relevant, anesthesia and recovery events, postoperative instructions, complication contacts, and follow-up decision. Marketing use of a patient's image needs a separate, specific authorization process; treatment consent is not a safe substitute.

For a revision or unexpected outcome, do not let the calendar decide who owns the conversation. Set a route for patient messages, photo review, in-person assessment, emergency direction, and transfer of care when the operating clinician is unavailable.

Match each clinician to the actual procedure

Job titles such as "injector," "laser technician," or "aesthetic provider" do not establish California authority. Build a role map for each service: the person who assesses candidacy, the person who orders or performs the procedure, the applicable license and practice arrangement, documented competence, physician availability where required, record access, and escalation role.

California Medical Board guidance is specific for some cosmetic services. It says that an MA may not inject Botox. Its laser and IPL guidance addresses particular treatments, not every laser, IPL, radiofrequency, or energy-device service. Name the actual service and license type, then use the governing statute, regulation, and Board guidance.

Vendor training is useful evidence of preparation. It does not substitute for lawful scope, facility privilege, clinical competence, or a plan for an adverse event.

Let the anesthetic risk decide the setting

Not every plastic-surgery procedure needs an outpatient-surgery setting because of its name. California's threshold turns on anesthesia other than local anesthesia or a peripheral nerve block at doses that have a probability of placing the patient at risk of loss of life-preserving protective reflexes. If the planned care reaches that threshold, it must occur only in a setting permitted by Health and Safety Code section 1248.1.

Do not use "MAC," "moderate sedation," or an office label as a substitute for the actual anesthetic plan. Map the medications and doses, patient assessment, anesthesia and monitoring roles, rescue capacity, recovery criteria, discharge plan, and transfer route for the specific service and site.

Facility privilege, accreditation, or a lease answers a different question from insurance. It may authorize or govern a setting, but it does not tell the practice whether an entity, clinician, procedure, or prior service period is insured.

Give implants, devices, and injectables their own clinical lane

For each implant, tissue product, filler, neurotoxin, laser, IPL, energy device, or compounded preparation, record the product identity, source, applicable labeling or instructions for use, storage, lot or serial traceability where appropriate, operator, setting, and patient-specific plan. A device brand or a cash-pay price does not describe the treatment.

FDA warns that dermal-filler injection can cause serious injury through accidental intravascular injection. The practice should be able to recognize the event, stop treatment, act within its competence, arrange prompt referral or transfer, document the response, and support the patient after hours. Do not use a generic complication script for every product or device.

Use CDC safe injection practices for medication preparation and administration. Device safety also depends on the actual model, instructions for use, training, eye or thermal safeguards where applicable, and a usable plan for device failure or recall.

For outpatient surgery outside a general acute-care hospital, California also requires the physician and surgeon to maintain adequate security for patient claims. The minimum set by regulation is $1 million per incident and $3 million annual aggregate. This statutory requirement does not make any particular insurer offer coverage or answer whether a policy covers the actual service.

Preserve clinical control across the business model

Map the professional practice, surgery center or facility entity, MSO, property entity, retail business, public brand, device owner, and staff employer. Then identify who controls patient records, clinical hiring and competence, treatment choices, medical supplies, protocols, scheduling, and patient-care billing decisions.

California's corporate-practice rules do not allow a nonprofessional business to control professional medical judgment. An MSO can provide administrative support, but a physician cannot serve as a nominal medical director for a lay-owned business offering cosmetic medical services. The lawful structure depends on the facts; map decision rights before relying on an ownership label or contract title.

Use policy review as the final evidence check

Give the carrier or broker the current clinical map: all surgeons and other clinicians; procedure and anesthesia services; facilities and mobile or event work; implants, devices, and products; related entities; after-hours roles; and any historical work that needs a continuing reporting path.

Then read the issued policy, declarations, definitions, endorsements, exclusions, limits, defense provisions, retroactive or prior-acts terms, and reporting conditions. Do not assume a shared logo, hospital privilege, facility contract, certificate, or product category identifies the insured entity or guarantees a response. A certificate is evidence of insurance, not the policy; coverage depends on the issued terms and claim facts.

Test the patient who does not follow the expected course

Run a postoperative bleeding call, a drain issue, a filler vascular event, a laser injury, a pathology result, an unreachable patient, and an after-hours photo review. If the team can name the current clinical owner, accessible record, local escalation route, entity named in the issued policy, and reporting contact under that policy, it has built a safer practice than one defined only by a procedure list.

San Diego plastic surgery rate-manual example

Filed rate rows show how selected carriers classified plastic surgery in the cited manual editions. They do not establish current premium or coverage for an actual practice.

Carrier Filed class Rate at $1M/$3M Manual Filing record
TDC Plastic Surgery $23,641 2014-10-01 (Ed. 10/14) TDC California Rate Pages Ed. 10/14; CDI filing 14-4043 / DCTR-129531290, approved 2014-08-07
MedPro Class 4 $26,910 2013-08-07 (Ed. 07/01/13) The Medical Protective Company, CA State Rate Pages Section III (SR-CA-III), Edition 07/01/13, Standard Claims-Made Mature tables; CDI filing 13-3635 / SERFF MDPC-129010877, approved 2013-08-07
NORCAL 1065 - Plastic Surgery $26,760 2015-09-28 (manual 08/01/2015) NORCAL Mutual Insurance Company, California Medical Professional Liability Insurance Underwriting Manual, 08/01/2015 (corrected copy), pp. 7-11; CDI filing 14-7766;14-7767 / SERFF NCMC-129678275, approved 2015-09-28
MIEC Plastic Surgery (class 24, rel 3.60) $38,917.80 2023-02-01 (Rev 2-1-2023) Medical Insurance Exchange of California, Countrywide Underwriting Manual - HPL (Rev 2-1-2023) with California State Exception Pages; CDI filing 20-4143 / SERFF PERR-132594120, approved 2023-02-07, effective 2023-02-01

The full comparison also lists the policy basis, territory mapping, and carrier notes.

Compare filed rates

Sources